Search Results

You are looking at 1 - 10 of 53 items for :

  • "chemoembolization" x
  • Refine by Access: All x
Clear All
Full access

Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries

Hanna K. Sanoff, YunKyung Chang, Joseph M. Stavas, Til Stürmer, and Jennifer Lund

cirrhosis: transarterial chemoembolization (TACE) and yttrium 90 (Y 90 ) radioembolization. TACE delivers chemotherapy directly to the cancer through the hepatic arterial system with subsequent arterial embolization, or through the contemporary approach of

Full access

Role of Interventional Radiology in the Treatment of Patients with Neuroendocrine Metastases in the Liver

Larry K. Kvols, Kiran K. Turaga, Jonathan Strosberg, and Junsung Choi

gastroenteropancreatic neuroendocrine tumors: place for chemoembolization . World J Surg 2001 ; 25 : 685 – 688 . 6 Blonski WC Reddy KR Shaked A . Liver transplantation for metastatic neuroendocrine tumor: a case report and review of the literature . World

Full access

Liver-Directed Therapies in Patients With Advanced Neuroendocrine Tumors

Natalie B. Jones, Manisha H. Shah, and Mark Bloomston

transplantation, and percutaneous interventions (e.g., ablation, chemoembolization, radioembolization). Given the propensity for poorly differentiated tumors to be treated with systemic therapy, this discussion is limited to the management of low-grade (i.e., well

Full access

Hepatobiliary Cancers

Al B. Benson III, Thomas A. Abrams, Edgar Ben-Josef, P. Mark Bloomston, Jean F. Botha, Bryan M. Clary, Anne Covey, Steven A. Curley, Michael I. D'Angelica, Rene Davila, William D. Ensminger, John F. Gibbs, Daniel Laheru, Mokenge P. Malafa, Jorge Marrero, Steven G. Meranze, Sean J. Mulvihill, James O. Park, James A. Posey, Jasgit Sachdev, Riad Salem, Elin R. Sigurdson, Constantinos Sofocleous, Jean-Nicolas Vauthey, Alan P. Venook, Laura Williams Goff, Yun Yen, and Andrew X. Zhu

. Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization . Cancer 2008 ; 112 : 352 – 361 . 72 Collette S Bonnetain F Paoletti X . Prognosis of advanced hepatocellular carcinoma

Full access

Medicare/Medicaid Insurance, Rurality, and Black Race Associated With Provision of Hepatocellular Carcinoma Treatment and Survival

Andrew M. Moon, Hanna K. Sanoff, YunKyung Chang, Jennifer L. Lund, A. Sidney Barritt IV, Paul H. Hayashi, and Karyn B. Stitzenberg

incident patients with HCC diagnosed between 2004 and 2012. Most patients diagnosed with HCC received no treatment every year during the study period. Abbreviations: HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization; Y90, yttrium-90

Full access

Geographic Variations of Potentially Curative Treatments for Hepatocellular Carcinoma in the United States: A SEER-Medicare Study

En Cheng, Peiyin Hung, and Shi-Yi Wang

chemoembolization (TACE), and chemotherapy. 3 – 6 Many studies have reported beneficial effects of these options—in particular, transplantation, surgical resection, RFA, and PEI are considered potentially curative treatments because these interventions can markedly

Full access

Liver-Directed Therapies for Hepatocellular Carcinoma

Cletus A. Arciero and Elin R. Sigurdson

. Colleoni M Audisio RA De Braud F . Practical considerations in the treatment of hepatocellular carcinoma . Drugs 1998 ; 55 : 367 – 382 . 63. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular

Full access

Integration of Systemic and Liver-Directed Therapies for Locally Advanced Hepatocellular Cancer: Harnessing Potential Synergy for New Therapeutic Horizons

Eric H. Bent, Eric Wehrenberg-Klee, Eugene J. Koay, Lipika Goyal, and Jennifer Y. Wo

advanced, multifocal, or unresectable HCC disease (BCLC stage B), locoregional therapies (LRTs) including trans-arterial chemoembolization (TACE), trans-arterial radioembolization (TARE), and external-beam radiation therapy (EBRT) are commonly considered

Full access

Therapeutic Delays Lead to Worse Survival Among Patients With Hepatocellular Carcinoma

Amit G. Singal, Akbar K. Waljee, Nishant Patel, Emerson Y. Chen, Jasmin A. Tiro, Jorge A. Marrero, and Adam C. Yopp

the Barcelona Clinic Liver Cancer (BCLC) staging system. 21 HCC treatments were categorized as liver transplantation, resection, radiofrequency ablation, transarterial chemoembolization (TACE), systemic chemotherapy, or best supportive care. In

Full access

Selection of Patients with Hepatocellular Carcinoma for Sorafenib

Ghassan K. Abou-Alfa

. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma . Hepatology 2002 ; 35 : 1164 – 1171 . 19 Pelletier G Roche A Ink O . A randomized trial of hepatic arterial chemoembolization in